Perceptive Advisors’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-2,038,880
Closed -$2.32M 173
2017
Q3
$2.32M Hold
2,038,880
0.09% 88
2017
Q2
$2.37M Sell
2,038,880
-111,120
-5% -$129K 0.12% 78
2017
Q1
$2.82M Buy
+2,150,000
New +$2.74M 0.16% 77

Perceptive Advisors's OCRX Position: Q4 2017 in Review

Perceptive Advisors sold out of Ocera Therapeutics, Inc. (OCRX) in Q4 2017, closing a stake of 2,038,880 shares — an estimated $2.32M sold.

Perceptive Advisors first reported a position in OCRX in Q1 2017 and held it in 3 quarters. The position peaked at $2.82M in Q1 2017. 0 funds tracked by Wall St. Rank hold OCRX as of Q4 2017.

  • Perceptive Advisors reported no remaining Ocera Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
  • Perceptive Advisors sold 2,038,880 Ocera Therapeutics, Inc. shares in Q4 2017, an estimated $2.32M.
  • Perceptive Advisors first reported a position in Ocera Therapeutics, Inc. in Q1 2017 and held it in 3 quarters.
  • Perceptive Advisors's Ocera Therapeutics, Inc. position peaked at $2.82M in Q1 2017.
  • 0 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q4 2017.

Based on Perceptive Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.